Biotech fundraising conditions brighten with bolder Fed rate cut

The Fed’s aggressive interest rate cut and a stance signaling more cuts to come in the near future herald a better environment for biotechs to raise capital.

The U.S. Federal Reserve’s long-awaited interest rate cut landed at the high end of expectations, with many analysts expecting a quarter point reduction. The cut, the first by the Fed since 2020, lowers the target range for the federal funds rate to 4.75% to 5%...